Sleep disorders

General Surgery Devices Market Size Worth $25 Billion by 2025: Grand View Research, Inc.

Retrieved on: 
Tuesday, May 15, 2018
Sleep disorders, Snoring, Surgery

Increase in investments in R&D pertaining to general surgery devices, commercialization of new devices are the factors responsible for propelling the growth of the market.

Key Points: 
  • Increase in investments in R&D pertaining to general surgery devices, commercialization of new devices are the factors responsible for propelling the growth of the market.
  • Browse related reports by Grand View Research:
    Anti-Snoring Devices And Snoring Surgery Market - The anti-snoring devices and snoring surgery market was estimated to be USD 750 million in 2015.
  • Cardiovascular Devices Market - The global cardiovascular devices market was valued over 33 billion in 2015 and is projected to grow at a CAGR of 6.6% over the forecast period.
  • Grand View Research has segmented the global general surgery devices market on the basis of type, component, delivery mode, application, end-use and region:

Jazz Pharmaceuticals to Highlight Breadth of Research in Narcolepsy and Excessive Sleepiness in Obstructive Sleep Apnea at SLEEP 2018 Annual Meeting

Retrieved on: 
Thursday, May 10, 2018
Neurochemistry, Neuroscience, Medicine, GHB, Sleep disorders, Narcolepsy, Sodium oxybate, Euphoriants, Excessive daytime sleepiness, gamma-Hydroxybutyric acid, Cataplexy, Jazz Pharmaceuticals

Jazz Pharmaceuticals has worldwide development, manufacturing, and commercialization rights to solriamfetol, excluding certain jurisdictions in Asia.

Key Points: 
  • Jazz Pharmaceuticals has worldwide development, manufacturing, and commercialization rights to solriamfetol, excluding certain jurisdictions in Asia.
  • Xyrem (sodium oxybate) oral solution, CIII, is indicated for the treatment of cataplexy in narcolepsy and for the treatment of excessive daytime sleepiness in narcolepsy.
  • The current United States Product Insert for Xyrem indicates that safety and effectiveness in pediatric patients have not been established.
  • Almost all of the patients who received Xyrem during clinical trials in narcolepsy were receiving central nervous system stimulants.

Jazz Pharmaceuticals Submits Supplemental New Drug Application for Xyrem® (sodium oxybate) to Treat Cataplexy and Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients

Retrieved on: 
Tuesday, May 1, 2018
Sleep disorders, Medicine, Neuroscience, Clinical medicine, Narcolepsy, Sodium oxybate, Excessive daytime sleepiness, Cataplexy, Somnolence, Stimulant, Idiopathic hypersomnia, Microsleep

In clinical trials at recommended doses obtundation and clinically significant respiratory depression occurred in Xyrem-treated patients.

Key Points: 
  • In clinical trials at recommended doses obtundation and clinically significant respiratory depression occurred in Xyrem-treated patients.
  • Almost all of the patients who received Xyrem during clinical trials in narcolepsy were receiving central nervous system stimulants.
  • Narcolepsy is a debilitating neurological disorder characterized by excessive sleepiness, and the inability to regulate sleep-wake cycles normally.
  • Of the five key symptoms of narcolepsy, excessive daytime sleepiness and cataplexy are the most common symptoms.

The sleep apnea devices market is projected to grow at a CAGR of 7.8%

Retrieved on: 
Thursday, April 26, 2018
Sleep disorders, Medicine, Sleep apnea, Apnea, Biology, Health

The sleep apnea devices market is projected to reach USD 6.49 billion by 2023 from an estimated USD 4.44 billion in 2018.

Key Points: 
  • The sleep apnea devices market is projected to reach USD 6.49 billion by 2023 from an estimated USD 4.44 billion in 2018.
  • On the basis of type, the sleep apnea devices market is segmented into therapeutic and diagnostic devices.The therapeutic devices segment accounted for the largest share of the global sleep apnea market.
  • Based on end user, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care/individuals.The home care/individuals segment is estimated to grow at the highest CAGR during the forecast period.
  • The sleep apnea devices market is divided into four major regions North America, Europe, Asia Pacific, and the Rest of the World.North America accounted for the largest share of the sleep apnea devices market.

Howard University Hospital Earns Sleep Center Accreditation

Retrieved on: 
Wednesday, April 25, 2018
Neuroscience, Sleep, Sleep disorders, Biology, Neurophysiology, American Academy of Sleep Medicine, Sleep medicine, Sleep apnea, International Classification of Sleep Disorders

WASHINGTON, April 25, 2018 /PRNewswire-USNewswire/ -- The Howard University Hospital (HUH) Sleep Disorders Center has been awarded a five-year accreditation by the American Academy of Sleep Medicine (AASM) for demonstrating a commitment to high quality, patient-centered care as well as exhibiting a dedication to the practice of sleep medicine.

Key Points: 
  • WASHINGTON, April 25, 2018 /PRNewswire-USNewswire/ -- The Howard University Hospital (HUH) Sleep Disorders Center has been awarded a five-year accreditation by the American Academy of Sleep Medicine (AASM) for demonstrating a commitment to high quality, patient-centered care as well as exhibiting a dedication to the practice of sleep medicine.
  • "We are extremely proud of our Sleep Disorders Center for setting a benchmark to achieve accreditation status," says Jim Diegel, HUH Chief Executive Officer.
  • To achieve accreditation, a sleep center must meet or exceed all standards for professional health care as designated by the AASM.
  • The HUH Sleep Disorders Center is a state-of-the-art facility that administers comprehensive in-center sleep and home sleep apnea testing to diagnose and treat all types of sleep disorders.

Individuals & Families Affected by Sleep Apnea Channel Experience to Improve Treatment Options

Retrieved on: 
Wednesday, April 25, 2018
Sleep disorders, Neuroscience, Biology, Physiology, Sleep apnea, Apnea, Sleep, ASAA, American Sleep Apnea Association, Central sleep apnea

The Centers for Disease Control and Prevention estimates that 50-75 percent of adults with symptoms of sleep apnea have not discussed their concerns with a physician.

Key Points: 
  • The Centers for Disease Control and Prevention estimates that 50-75 percent of adults with symptoms of sleep apnea have not discussed their concerns with a physician.
  • "30 years after I first showed signs of sleep apnea, I finally received a diagnosis and appropriate therapy.
  • Now I do all I can to help others avoid that long and risky odyssey and to improve treatment options for all.
  • For more information about AWAKE Sleep Apnea, the June 8, 2018 meeting, the online survey, ASAA, and initiative partners, visit www.awakesleepapnea.org .

Sleep Apnea Devices Market Worth 6.49 Billion USD by 2023

Retrieved on: 
Friday, April 20, 2018
Sleep disorders, Medicine, Health, Sleep apnea, Clinical medicine, ResMed, Mandibular advancement splint, Fisher & Paykel Healthcare, APAP, Central sleep apnea

According to a new market research report "Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device), Diagnostic (PSG, Oximeter)), End User (Sleep Laboratories & Hospitals, Home Care/Individuals) - Global Forecasts to 2023", published by MarketsandMarkets, the market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018, at a CAGR of 7.8%.

Key Points: 
  • According to a new market research report "Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device), Diagnostic (PSG, Oximeter)), End User (Sleep Laboratories & Hospitals, Home Care/Individuals) - Global Forecasts to 2023", published by MarketsandMarkets, the market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018, at a CAGR of 7.8%.
  • The major end users of sleep apnea devices include sleep laboratories & hospitals and home care/individuals.
  • North America is expected to account for the largest share of the Sleep Apnea Devices Market in 2018, followed by Europe.
  • ResMed (US), Koninklijke Philips (Netherlands), and Fisher & Paykel Healthcare (New Zealand) are the key players in the Sleep Apnea Devices Market.

U.S. Sleep Market 2018: Competitive & Operating Analysis 1995-2017 & 2018-2023 Featuring ResMed, Respironics, SleepMed, Novasom, Tempur Sealy, Sleep Numbero & Simmons Serta

Retrieved on: 
Friday, April 20, 2018
Sleep disorders, Sleep, Neuroscience, Biology, Insomnia, Sleep sex, International Classification of Sleep Disorders

The "The U.S. Sleep Market 2018: Competitive & Operating Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The U.S. Sleep Market 2018: Competitive & Operating Analysis" report has been added to ResearchAndMarkets.com's offering.
  • Of a total population of 325 million Americans, 58% are estimated to experience insomnia symptoms or sleep disorders.
  • As obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders.
  • size 1997-2023 F
    Major Market Trends: discussion of sleep lab reimbursement and consolidation, home test market, decline of Rx sleep medications mkt.

Later middle school start times help teens catch up on sleep, according to study from Children's National Health System

Retrieved on: 
Tuesday, April 17, 2018
Sleep, Sleep disorders, Neuroscience, Biology

This study capitalized on the opportunity to analyze different start times for seventh and eighth graders within one school district.

Key Points: 
  • This study capitalized on the opportunity to analyze different start times for seventh and eighth graders within one school district.
  • Dr. Lewin and the researchers measured the impact later school start times have on student bedtimes, sleep duration, and daytime sleepiness.
  • They chose to study these variables in middle school students since the majority of research about school start times is conducted in high schools.
  • This review appears in the May 2018 edition of Journal of School Health , a peer-reviewed journal published by the American School Health Association.